Evidence map›Paper›PMID 24717516›Full record

ReviewEpigenetics2014

Epigenetic regulation of the placental HSD11B2 barrier and its role as a critical regulator of fetal development.

Katie L Togher, Katie L Togher, Majella M O'Keeffe, Majella M O'Keeffe, Ali S Khashan, Ali S Khashan, Humberto Gutierrez, Humberto Gutierrez, Louise C Kenny, Louise C Kenny and 2 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Epigenetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
12.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Placental adaptation to maternal environment in domestic animals.The Journal of reproduction and development · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Differential Placental DNA Methylation ofFrontiers in pediatrics · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Katie L TogherIrish Centre for Fetal and Neonatal Translational Research (INFANT); Cork University Maternity Hospital; Cork, Ireland; Department of Obstetrics and Gynaecology; Cork University Maternity Hospital; Cork, Ireland; Department of Anatomy and Neuroscience; Biosciences Institute; University College Cork; Cork, Ireland.
Katie L TogherIrish Centre for Fetal and Neonatal Translational Research (INFANT); Cork University Maternity Hospital; Cork, Ireland; Department of Obstetrics and Gynaecology; Cork University Maternity Hospital; Cork, Ireland; Department of Anatomy and Neuroscience; Biosciences Institute; University College Cork; Cork, Ireland.
Majella M O'KeeffeDepartment of Nutrition and Dietetics; School of Medicine; Kings College London; London, UK.
Majella M O'KeeffeDepartment of Nutrition and Dietetics; School of Medicine; Kings College London; London, UK.
Ali S KhashanIrish Centre for Fetal and Neonatal Translational Research (INFANT); Cork University Maternity Hospital; Cork, Ireland; Department of Obstetrics and Gynaecology; Cork University Maternity Hospital; Cork, Ireland.
Ali S KhashanIrish Centre for Fetal and Neonatal Translational Research (INFANT); Cork University Maternity Hospital; Cork, Ireland; Department of Obstetrics and Gynaecology; Cork University Maternity Hospital; Cork, Ireland.
Humberto GutierrezUniversity of Lincoln; Brayford Pool; Lincoln UK.
Humberto GutierrezUniversity of Lincoln; Brayford Pool; Lincoln UK.
Louise C KennyIrish Centre for Fetal and Neonatal Translational Research (INFANT); Cork University Maternity Hospital; Cork, Ireland; Department of Obstetrics and Gynaecology; Cork University Maternity Hospital; Cork, Ireland.
Louise C KennyIrish Centre for Fetal and Neonatal Translational Research (INFANT); Cork University Maternity Hospital; Cork, Ireland; Department of Obstetrics and Gynaecology; Cork University Maternity Hospital; Cork, Ireland.
Gerard W O'KeeffeIrish Centre for Fetal and Neonatal Translational Research (INFANT); Cork University Maternity Hospital; Cork, Ireland; Department of Anatomy and Neuroscience; Biosciences Institute; University College Cork; Cork, Ireland.
Gerard W O'KeeffeIrish Centre for Fetal and Neonatal Translational Research (INFANT); Cork University Maternity Hospital; Cork, Ireland; Department of Anatomy and Neuroscience; Biosciences Institute; University College Cork; Cork, Ireland.
Cork University Hospital · IEUniversity of Lincoln · GBIndiana University School of MedicineKing's College - North Carolina · USUniversity College Cork · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

"Fetal programming" is a term used to describe how early-life experience influences fetal development and later disease risk. In humans, prenatal stress-induced fetal programming is associated with increased risk of preterm birth, and a heightened risk of metabolic and neurological diseases later in life. A critical determinant of this is the regulation of fetal exposure to glucocorticoids by the placenta. Glucocorticoids are the mediators through which maternal stress influences fetal development. Excessive fetal glucocorticoid exposure during pregnancy results in low birth weight and abnormalities in a number of tissues. The amount of fetal exposure to maternal glucocorticoids depends on the expression of HSD11B2, an enzyme predominantly produced by the syncytiotrophoblast in the placenta. This protects the fetus by converting active glucocorticoids into inactive forms. In this review we examine recent findings regarding placental HSD11B2 that suggest that its epigenetic regulation may mechanistically link maternal stress and long-term health consequences in affected offspring.

Indexed as

Epigenesis, GeneticFetal Development11-beta-Hydroxysteroid Dehydrogenase Type 2DietFemaleFetal DiseasesGlucocorticoidsHumansInfant, Low Birth WeightInfant, NewbornMaleMaternal ExposureMaternal-Fetal ExchangePlacentaPregnancyPrenatal Exposure Delayed Effects11-beta-Hydroxysteroid Dehydrogenase Type 2GlucocorticoidsHSD11B2 protein, human11β-hydroxysteroid dehydrogenase type-2epigeneticfetal outcomeplacentaprenatal stress

Identifiers

PMID24717516
PMCPMC4065178
OpenAlexW1964039691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.